Loading...
+1-9179056297
contact@mkscienceset.com

Become A Member – Exclusive Author Offer Join Our Exclusive Author Membership Program And Enjoy Unlimited Publications For One Year At A Special Discounted Rate Of $3,999 (Regular Fee: $15,000). Limited-Time Offer Valid Until January 2026.

Biopharmaceuticals Tier -3 Antibiotics for Prognosis and Dual Treatement of Bacterial and Viral Conditions

Abstract:
This study explores the role of tier-3 biopharmaceutical antibiotics in the prognosis and dual treatment of bacterial and viral infections. Through a five-year clinical observation, improper antibiotic prescriptions were linked to exac erbated pulmonary conditions. A novel treatment protocol incorporating antibiotics, antivirals, and immunotherapy demonstrated efficacy in reversing chronic bronchial disorders. The research underscores the importance of precise pharmaceutical interventions and regulatory oversight in managing infectious diseases.